Circulation, Vol 85, 54-60, Copyright © 1992 by American Heart Association
G Jondeau, M Klapholz, SD Katz, M Maher, M Galvao, P Levato and TH LeJemtel
BACKGROUND. The vasodilatory response to local specific type III
phosphodiesterase inhibition with amrinone was evaluated before and
immediately after local administration of digoxin in 14 patients with
severe congestive heart failure (CHF). METHODS AND RESULTS. A 3F
polyethylene catheter was inserted into the common femoral artery for drug
administration and pressure monitoring. Mean blood flow velocity (MBFV) was
continuously determined in the superficial femoral artery by transcutaneous
Doppler ultrasonography. After intra-arterial administration of 10 mg
amrinone, group MBFV increased from 7.7 +/- 1.4 to 16.0 +/- 2.1 cm/sec (p
less than 0.05, n = 10). Local administration of 20 micrograms digoxin,
which was infused over 20 minutes, did not alter group MBFV (i.e., 8.2 +/-
1.6 versus 7.6 +/- 1.5 cm/sec; p = NS, n = 10). The second administration
of 10 mg amrinone, which immediately followed completion of local digoxin
infusion, increased group MBFV but to a lesser extent than that produced by
the first amrinone administration (i.e., 11.9 +/- 1.9 versus 16.0 +/- 2.1
cm/sec; p less than 0.05, n = 10). When placebo was administered instead of
digoxin, group MBFV was similar after the first and second administrations
of amrinone (i.e., 15.3 +/- 3.3 versus 15.6 +/- 3.8 cm/sec; p = NS, n = 4).
CONCLUSIONS. Although local administration of digoxin did not significantly
alter baseline vascular tone in patients with CHF, it substantially
decreased the direct vasodilatory effect induced by specific type III
phosphodiesterase with amrinone.
ARTICLES
Control of arteriolar resistance in heart failure. Partial attenuation of specific phosphodiesterase inhibitor-mediated vasodilation by digitalis glycosides
Department of Medicine, Albert Einstein College of Medicine, Bronx, N.Y.
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |